AYA vs CGS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AYA

ARTRYA FPO [AYA]

55MEDIUM

CGS

COGSTATE FPO [CGS]

58MEDIUM

Score Breakdown

AYA CGS
Technical
62
47
Catalyst
57
53
Sentiment
50
50
Fundamental
90
96
Momentum
80
79
Risk Gate
50
50

Key Metrics

AYA Metric CGS
$924.2MMarket Cap$489.3M
801KAvg Volume (20d)397K
+0.9%Short Interest+0.1%
$6.49052-Week High$3.010
$0.86552-Week Low$1.550
+1.2%Daily Change-3.5%
$5.720Reference Price$2.780
-37.9%ROE+22.5%
N/AProfit Margin+19.2%

Active Signals

AYA Signals

●MACD momentum is losing steam
●Stochastic just turned bullish from a low level — early reversal sign
●Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (15 quarters)
●Very high P/S ratio (31868.8x)
●Moderate revenue growth (+8%)
●EPS estimates revised upward (+10pts)

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare AYA and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AYA vs CMP →AYA vs EIQ →AYA vs EMD →AYA vs EPN →AYA vs EYE →
AYA Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).